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Abstract
Aims: Postsynaptic density – 95 kDa protein (PSD95) is an important molecule on the postsynaptic membrane. It
interacts with many other proteins and plays a pivotal role in learning and memory formation. Its distribution in the
brain has been studied previously using in situ hybridization as well as immunohistochemistry. However, these
studies are based on 2 dimensional (2D) sections and results are presented with a few sections. The present study
aims to show PSD-95 distribution in 3 dimensions (3D) without slicing the brain tissue of C57BL/6 mice into
sections using the advanced CUBIC technique.
Methods: Immunofluorescent staining using a PSD-95 antibody was performed on a half of the mouse brain after
clarifying it using the advanced CUBIC protocol. The brain tissue was imaged using a Zeiss Z1 light sheet
microscope and 3D reconstruction was completed using the Arivis Vision 4 dimensional (4D) software.
Results: The majority of brain nuclei have similar distribution pattern to what has been reported from in situ
hybridization and immunohistochemical studies in the mouse. The signal can be easily followed in the 3D and their
spatial relationship with adjacent structures clearly demarcated. In the present study, some fiber bundles also
showed strong PSD-95 signal, which is different from what was shown in previous studies and need to be
confirmed in future studies.
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Main text
Postsynaptic density protein of 95 kDa (PSD-95) is a
scaffolding protein encoded by the disc large homolog
4 (DLG4) gene. It is highly enriched in the postsynaptic
membrane and interacts with multiple synaptic proteins
[1] through its three Post synaptic density protein,
Drosophila disc large tumor suppressor, and Zonula
occludens-1 protein (PDZ) domains. It plays an import-
ant role in synaptic plasticity [2], learning and memory
[3], and other functions depending on the proteins it
binds to. The expression of PSD-95 in the mouse brain
has been described in traditional studies [4–6]. PSD-95
is highly expressed in the cerebral cortex, hippocampus,
and striatum, and only moderately or weakly expressed
in other brain regions. Our research has focused on the
molecular and histological changes in the brain of dis-
rupted in schizophrenia 1-locus impairment (DISC1-LI)
mice, which is known to be relevant to the neuropath-
ology of schizophrenia. The 3D imaging results pre-
sented here were from the C57BL/6 mouse as part of
our histological analysis comparing the expression
changes of PSD-95 in DISC1-LI mice with that of con-
trol C57BL/6 mice in the 3D space.
Brains of 12-week old C57BL/6 male mice were fixed
with 4% paraformaldehyde and dissected before being
cut into two halves sagittally. Immunofluorescent stain-
ing using a PSD-95 antibody was performed on a half of
the brains after clarifying them using the advanced
CUBIC protocol [7]. The brain tissue was imaged with a
Zeiss Z1 light sheet microscope using a 20× clearing
objective and 3D reconstruction was completed using
the Arivis Vision 4 dimensional (4D) software.
In the forebrain, we found strong positive PSD-95 signal
in the internal plexiform and the mitral cell layers of the
olfactory bulb (Fig. 1a and b), which was similar to what
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has been reported in the in situ hybridization [4, 8, 9] and
immunohistochemistry studies [5, 6].
Ventral to the cerebral cortex, which had weak
PSD-95 signal, moderate signal was observed in the cor-
pus callosum except the area dorsal to the hippocam-
pus (Fig. 1b and c). The positive signal in this stripe was
aligned in the same direction as that observed in the
caudate putamen, radiating towards the meeting point of
the stria terminalis and the internal capsule, which is
consistent with results from other studies [4–6, 9]. The
hippocampal fissure showed a narrow line of weak signal
(Fig. 1b and c), which is in contrast to what was reported
in a study using lacZ [6]. In a human postmortem study,
it was reported that schizophrenia and bipolar patients
showed a lower level of PSD-95 in the hippocampus, espe-
cially in the molecular layer of the dentate gyrus, suggest-
ing the diagnostic value of PSD-95 in the reported
diseases [10].
Strong signal was also found in the anterior part of the
anterior commissure, the fornix, the optic nerve, and the
cerebral peduncle ventral to the substantia nigra (Fig. 1b
and c). This is in a clear contrast to what has been re-
ported in the lacZ gene knockin mice [6] and other in
situ hybridization [4, 9] as well as immunohistochemical
Fig. 1 Fluorescent staining with a PSD-95 antibody on the clarified mouse brain. a. PSD-95 positive signal in a 3D rendered image. b. PSD-95
positive signal in a 2D image. The top is the rostral part, the bottom is the caudal part, the left is the dorsal part, and the right is the ventral part
of the mouse brain. c. PSD-95 positive signal in the forebrain. Note: strongly positive signal in the corpus callosum, anterior commissure, fornix;
moderate signal in other brain areas. The gray matter of the hippocampus does not have PSD-95 positive signal
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studies [5]. In those studies, most if not all fiber tracts
are void of PSD-95 signal. Moderate signal was observed
in the shell of accumbens nucleus, the ventral pallidum,
and the nucleus of horizontal diagonal band, the lateral
preoptic area, and the majority of hypothalamic nuclei. In
the thalamus, its rostral half had moderate PSD-95 sig-
nal, whereas the caudal half did not have or had weak
PSD-95 signal (Fig. 1b and c). This is different from
what has been reported by Porter et al. [6].
Positive signal was observed in the majority of mid-
brain nuclei and nuclei in the rostral hindbrain (the rest
of the hindbrain and cerebellum were cut off ). Positive
signal in the midbrain and the hypothalamus tended to
follow the course of large fibers travelling rostrocaudally.
In the middle part of the midbrain in sagittal sections, a
small band of signal appeared to travel dorsoventrally.
Ventral to this band, positive signals converge towards
the ventral surface of the hindbrain (Fig. 1b). These fea-
tures were not observed in previous in situ hybridization
and immunohistochemical studies.
The present study showed the expression of PSD-95
in the mouse brain using an emerging 3D technique –
advanced CUBIC and this study confirmed some previ-
ous reports about PSD-95 in the majority of brain nu-
clei (Additional file 1). We showed that some fiber
bundles were positive for PSD95, which has not been
reported in previous studies. To verify this concern, we
used Western blot (not shown) and confirmed the spe-
cificity of our PSD95 antibody. Our finding might be
true due to the fact that lipid of the neuropil has been
removed by the clearing solution and the antibody can
easily bind to the epitope of PSD-95, whereas in con-
ventional sections, there is no such a step and the inter-
action between PSD-95 and its antibody may be
blocked to some extent, especially in a fiber bundle
where the fibers are tightly bound to each other.
The present study did not include the entire hind-
brain due to difficulty in mounting the clarified tissue,
which was very soft, to the glass capillary for imaging.
Based on the findings from the rostral hindbrain,
which are similar to what has been shown in in situ
hybridization studies [4, 9], it is expected that the ma-
jority of hindbrain nuclei will have weak to moderate
PSD-95 signal. The cerebellum might have a higher
level of signal than the other areas in the hindbrain as
indicated by the in situ hybridization studies.
The advanced CUBIC is an efficient technique in clari-
fying the mouse brain tissue (Additional file 2). For the
same reason, it might lead to more protein loss than
passive Clear Lipid-exchanged Acrylamide-hybridized
Rigid Imaging/ Immunostaining/In situ hybridization-
compatible Tissue hYdrogel (CLARITY) and other
similar techniques. Currently, no method is ideal for
preserving protein and rendering tissue transparent for
imaging. Better clearing and imaging techniques with
longer working distance will be in demand in order to
show tissue integrity in the 3D video.
Additional files
Additional file 1: 3D video of fluorescent PSD-95 signal reconstructed
using Arivis. Strong fluorescent signal was observed in the large fiber
bundles such as the anterior commissure, fornix, stria terminalis of the
thalamus, and corpus callosum. Weak to moderate signal was observed
in a large number of nuclei in the forebrain and midbrain. (AVI 34006 kb)
Additional file 2: Materials and methods. (DOC 30 kb)
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DLG4: Disc large homolog 4 gene; f: Fornix; fi: Fimbria of hippocampus;
ic: Internal capsule; MAGUK: Membrane associated guanylate kinase;
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